back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2025-03-20 18:11 Tx date 2025-03-18 |
$INNO
InnoCan Pharma Corporation |
Mayron, Ron
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: IBI Trust Management (Control or Direction)
|
Common Shares
57 - Exercise of rights
|
$37,333
+177,778 vol $0.21 each |
1,583,332 | |
| Filed 2025-03-20 18:11 Tx date 2025-03-18 |
$INNO
InnoCan Pharma Corporation |
Mayron, Ron
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
38 - Redemption, retraction, cancellation, repurchase
|
-1 vol |
0 | |
| Filed 2025-03-20 18:10 Tx date 2025-03-18 |
$INNO
InnoCan Pharma Corporation |
Mayron, Ron
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
-177,778 vol |
1 | |
| Filed 2024-09-23 14:06 Tx date 2024-09-20 |
$INNO
InnoCan Pharma Corporation |
Mayron, Ron
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: IBI Trust Management (Control or Direction)
|
Common Shares
57 - Exercise of rights
|
$42,666
+177,777 vol $0.24 each |
1,405,554 | |
| Filed 2024-09-23 14:05 Tx date 2024-09-20 |
$INNO
InnoCan Pharma Corporation |
Mayron, Ron
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
-177,777 vol |
177,779 | |
| Filed 2024-09-23 09:54 Tx date 2024-09-16 |
$INNO
InnoCan Pharma Corporation |
Mayron, Ron
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
-177,777 vol |
||
| Filed 2024-09-23 09:54 Tx date 2024-09-16 |
$INNO
InnoCan Pharma Corporation |
Mayron, Ron
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: IBI Trust Management (Control or Direction)
|
Common Shares
57 - Exercise of rights
|
$42,666
+177,777 vol $0.24 each |
||
| Filed 2024-09-20 20:06 Tx date 2024-09-16 |
$INNO
InnoCan Pharma Corporation |
Mayron, Ron
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: IBI Trust Management (Control or Direction)
|
Common Shares
57 - Exercise of rights
|
$42,666
+177,777 vol $0.24 each |
||
| Filed 2024-09-20 20:06 Tx date 2024-09-16 |
$INNO
InnoCan Pharma Corporation |
Mayron, Ron
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
-177,777 vol |
||
| Filed 2024-09-20 20:06 Tx date 2024-09-16 |
$INNO
InnoCan Pharma Corporation |
Mayron, Ron
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: IBI Trust Management (Control or Direction)
|
Common Shares
57 - Exercise of rights
|
$42,666
+177,777 vol $0.24 each |
1,405,554 | |
| Filed 2024-09-20 20:06 Tx date 2024-09-16 |
$INNO
InnoCan Pharma Corporation |
Mayron, Ron
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
-177,777 vol |
177,779 | |
| Filed 2024-03-28 10:28 Tx date 2024-03-25 |
$INNO
InnoCan Pharma Corporation |
Mayron, Ron
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: IBI Trust Management (Control or Direction)
|
Common Shares
57 - Exercise of rights
|
+1,050,000 vol |
1,227,777 | |
| Filed 2024-03-28 10:28 Tx date 2024-03-25 |
$INNO
InnoCan Pharma Corporation |
Mayron, Ron
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: IBI Trust Management (Control or Direction)
|
Common Shares
57 - Exercise of rights
|
+177,777 vol |
177,777 | |
| Filed 2024-03-28 10:27 Tx date 2019-09-13 |
$INNO
InnoCan Pharma Corporation |
Mayron, Ron
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: IBI Trust Management (Control or Direction)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2024-03-28 10:27 Tx date 2024-03-25 |
$INNO
InnoCan Pharma Corporation |
Mayron, Ron
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
-1,050,000 vol |
355,556 | |
| Filed 2024-03-28 10:26 Tx date 2024-03-25 |
$INNO
InnoCan Pharma Corporation |
Mayron, Ron
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
-177,777 vol |
1,405,556 | |
| Filed 2024-03-18 11:58 Tx date 2024-03-14 |
$INNO
InnoCan Pharma Corporation |
Mayron, Ron
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+1,050,000 vol |
1,583,333 | |
| Filed 2024-03-18 11:57 Tx date 2024-03-14 |
$INNO
InnoCan Pharma Corporation |
Mayron, Ron
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+533,333 vol |
533,333 | |
| Filed 2024-03-18 11:57 Tx date 2019-09-13 |
$INNO
InnoCan Pharma Corporation |
Mayron, Ron
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2023-08-15 15:58 Tx date 2023-08-11 |
$INNO
InnoCan Pharma Corporation |
Mayron, Ron
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+700,000 vol |
3,200,000 |